Kashiv BioSciences
Piscataway
About Kashiv BioSciences
Kashiv BioSciences is a fully integrated biopharmaceutical company engaged in the development and manufacturing of complex pharmaceuticals, including biosimilars, applications, and complex generics. The company's infrastructure encompasses research and development facilities in Piscataway, New Jersey; Chicago, Illinois; and Ahmedabad, India, supporting capabilities such as mammalian and microbial cell line development, advanced analytical characterization, and commercial-scale manufacturing. Kashiv's product pipeline includes biosimilar candidates like KSHB002, an abatacept biosimilar that met primary endpoints in a Phase I trial.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $222.3M
- Funding stage: Seed
- Last round: Debt Financing (Dec 2025)
- Website: kashivbiosciences.com
- Phone: 732.475.0500
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/kashiv-biosciences-44276 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.